Recommended reading: Extrahepatic Bile Duct Cancer Treatment (PDQ®): Patient Version
PubMed Health. A service of the National Library of Medicine, National Institutes of Health.
A.D.A.M. Medical Encyclopedia [Internet]. Atlanta (GA): A.D.A.M.; 2013.
A.D.A.M. Medical Encyclopedia.
Cholangiocarcinoma is a cancerous (malignant) growth in one of the ducts that carries bile from the liver to the small intestine.
Causes, incidence, and risk factors
Cancerous tumors of the bile ducts are usually slow-growing and do not spread (metastasize) quickly. However, many of these tumors are already advanced by the time they are found.
A cholangiocarcinoma may start anywhere along the bile ducts. These tumors block off the bile ducts.
They affect both men and women. Most patients are older than 65.
Risks for this condition include:
- Bile duct (choledochal) cysts
- Chronic biliary and liver inflammation
- History of infection with the parasitic worm, liver flukes
- Primary sclerosing cholangitis
- Ulcerative colitis
Cholangiocarcinoma is rare. It occurs in approximately 2 out of 100,000 people.
Symptoms
- Chills
- Clay-colored stools
- Pain in the upper right abdomen that may radiate to the back
- Yellowing of the skin (jaundice)
Signs and tests
Your health care provider will perform a physical exam. Tests will be done to check for a tumor or blockage in the bile duct. These may include:
- Cytology of samples from the bile duct
- Endoscopic retrograde cholangiopancreatography (ERCP)
- Magnetic resonance cholangiopancreatography (MRCP)
- Percutaneous transhepatic cholangiogram (PTCA)
Blood tests that may be done include:
- Liver function tests (especially alkaline phosphatase or bilirubin levels)
Treatment
The goal is to treat the cancer and the blockage it causes. When possible, surgery to remove the tumor is the treatment of choice and may result in a cure. If the tumor is large, the entire liver may need to be removed and a liver transplant will be needed. However, often the cancer has already spread by the time it is diagnosed.
Chemotherapy or radiation may be given after surgery to decrease the risk of the cancer returning. However, the benefit of this treatment is not certain.
Endoscopic therapy with stent placement can temporarily relieve blockages in the biliary ducts and relieve jaundice in patients when the tumor cannot be removed. Laser therapy combined with light-activated chemotherapy medications is another treatment option for those with blockages of the bile duct.
Support Groups
You can ease the stress of illness by joining a support group with members who share common experiences and problems (see cancer - support group).
Hospice is often a good resource for patients with cholangiocarcinoma that cannot be cured.
Expectations (prognosis)
Completely removing the tumor allows approximately 1 in 5 patients to survive for at least 5 years, with the possibility of a complete cure.
If the tumor cannot be completely removed, a cure is generally not possible. With treatment, about half of these patients live a year, and about half live longer.
Complications
- Infection
- Liver failure
- Spread (metastasis) of tumor to other organs
Calling your health care provider
Call your health care provider if you have jaundice or other symptoms of cholangiocarcinoma.
References
- Lewis RL. Liver and biliary tract tumors. In Goldman L,Schafer AI, eds. Cecil Medicine. 24th ed. Philadelphia, PA: Saunders Elsevier; 2011:chap 202.
- National Comprehensive Cancer Network. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Hepatobiliary cancers. 2012. Version 2.2012.
Review Date: 6/5/2012.
Reviewed by: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine. Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M. Health Solutions, Ebix, Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only — they do not constitute endorsementscof those other sites. © 1997–2011 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
No evidence to support or refute endoscopic retrograde cholangiopancreaticography (ERCP) with stenting in patients with malignant pancreaticobiliary diseases, awaiting surgery
Pancreatico‐biliary malignancy includes cancers of pancreas, ampulla, duodenum, and cholangiocarcinoma. There is significant morbidity and mortality related to surgery in these patients. Studies have claimed the beneficial role of biliary decompression, which can be performed via endoscopic retrograde cholangiopancreaticography (ERCP) with stent insertion pre‐surgically. The review found that pre‐surgical biliary stenting via ERCP did not improve the morbidity and mortality in patients with pancreatico‐biliary malignancy. Further evidence about its efficiency is needed.
How we know if a treatment worksTesting Treatments is a lively look at modern clinical research, and how everyone can get involved in using and improving research for better health care.
- CholangiocarcinomaCholangiocarcinomaPubMed Health
Your browsing activity is empty.
Activity recording is turned off.
See more...
